Daiwa Securities Group
KRTX

Daiwa Securities Group’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Daiwa Securities Group’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-154
Closed -$49K – 1364
2023
Q4 		$49K Buy
154
+16
+12% +$3.11K ﹤0.01% 1076
2023
Q3 		$23K Hold
138
– – ﹤0.01% 1092
2023
Q2 		$30K Hold
138
– – ﹤0.01% 1092
2023
Q1 		$25K Hold
138
– – ﹤0.01% 1069
2022
Q4 		$27K Buy
138
+16
+13% +$3.43K ﹤0.01% 1074
2022
Q3 		$27K Buy
122
+11
+10% +$2.23K ﹤0.01% 1091
2022
Q2 		$14K Buy
111
+25
+29% +$2.87K ﹤0.01% 1129
2022
Q1 		$11K Hold
86
– – ﹤0.01% 1136
2021
Q4 		$11K Sell
86
-15
-15% -$1.94K ﹤0.01% 1149
2021
Q3 		$12K Buy
101
+47
+87% +$5.43K ﹤0.01% 1124
2021
Q2 		$6K Hold
54
– – ﹤0.01% 1068
2021
Q1 		$6K Buy
54
+4
+8% +$453 ﹤0.01% 1072
2020
Q4 		$5K Sell
50
-97
-66% -$8.99K ﹤0.01% 1063
2020
Q3 		$11K Hold
147
– – ﹤0.01% 1035
2020
Q2 		$11K Hold
147
– – ﹤0.01% 1065
2020
Q1 		$11K Hold
147
– – ﹤0.01% 1056
2019
Q4 		$11K Buy
+147
New +$6.44K ﹤0.01% 1056

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Daiwa Securities Group's KRTX Position: Q1 2024 in Review

Daiwa Securities Group sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 154 shares — an estimated $49K sold.

Daiwa Securities Group first reported a position in KRTX in Q4 2019 and held it in 17 quarters. The position peaked at $49K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Daiwa Securities Group reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Daiwa Securities Group sold 154 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $49K.
  • Daiwa Securities Group first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2019 and held it in 17 quarters.
  • Daiwa Securities Group's Karuna Therapeutics, Inc. Common Stock position peaked at $49K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Daiwa Securities Group's 13F filing for Q1 2024, filed 2 May 2024.